You just read:

Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting

News provided by

Ardelyx

Oct 19, 2016, 07:00 ET